Search
Search Results
##search.searchResults.foundPlural##
-
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1575PDF: 901HTML: 1000figures: 199table 1: 199table2: 196table3: 199 -
The ASSOCIATED FACTORS ON CYTOMEGALOVIRUS REACTIVATION OF CRITICALLY ILL IMMUNOCOMPETENT PATIENTS Cytomegalovirus Reactivation of Critically Ill Patients.
134PDF: 138HTML: 9 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
871PDF: 490HTML: 1310 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3814PDF: 1618HTML: 680Figures . Eliassian: 235 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
979PDF: 578HTML: 2211Cover Letter: 202 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
1011PDF: 542HTML: 731 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4138Suppl. Files: 1184PDF: 1102Html: 242 -
IMMUNOLOGY OF TUBERCULOSIS
5499PDF: 2042HTML: 7346Untitled: 206 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1461PDF: 1350HTML: 111 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2186PDF: 1200HTML: 281 -
-
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3095PDF: 1035HTML: 3140 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1213PDF: 847HTML: 2190Figue 1: 183 -
-
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3752PDF: 1260HTML: 3911Untitled: 240Untitled: 277 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1820PDF: 558HTML: 16986Figure 4: 179Figure 3: 151Figure 2: 157Figure 1: 194 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3412PDF: 1388HTML: 2703 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4875PDF: 1832HTML: 2781Untitled: 237 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3388PDF: 1350HTML: 6255 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1250PDF: 941HTML: 314 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1382PDF: 1031HTML: 128 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3356PDF: 1273HTML: 8232 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1665PDF: 811HTML: 871jdoe, table 2 infections CML .doc: 205jdoe, table 1 infections CML .doc: 195 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4508PDF: 1749HTML: 1111 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
2010PDF: 1073HTML: 304







